Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer.
about
Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer.Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial DataGene signatures of drug resistance predict patient survival in colorectal cancerCharacterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutationsValidation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin.Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.Multiplexed Dosing Assays by Digitally Definable Hydrogel Volumes.Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.Scandinavian Journal of Gastroenterology. Editorial.Development of an Experimental Model for Analyzing Drug Resistance in Colorectal Cancer.
P2860
Q27852685-839A37EE-BA18-4D1E-A68C-F85602649E3CQ28552023-6D259956-F8F4-48DA-9ECA-17215EAA9DFEQ35237150-F74B7AC0-4845-44C8-988F-2EF20CCE777AQ36749303-1D56FEB5-808B-4F64-922B-C0939E9C370DQ37411227-17FB2488-1C04-4B01-A360-7BCA77C1FF5DQ38430639-B4AF3F70-D542-4FFF-82E0-7A62699EA19CQ38815777-341372EC-713F-4B43-A775-8E206E7E0B85Q38901400-2BE147B8-2FF1-4203-AF76-E050020ECBCDQ41495258-DE41FCAE-7F24-4E79-A2FB-F923E72E86ECQ48515839-B9E6BF98-B7C5-4B7D-9E8A-6A7CDAB3F07AQ55456514-5E5D4FD2-1528-4B79-9FE7-D8DD0FAF8A52
P2860
Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Predictive biomarkers with pot ...... metastatic colorectal cancer.
@en
Predictive biomarkers with pot ...... metastatic colorectal cancer.
@nl
type
label
Predictive biomarkers with pot ...... metastatic colorectal cancer.
@en
Predictive biomarkers with pot ...... metastatic colorectal cancer.
@nl
prefLabel
Predictive biomarkers with pot ...... metastatic colorectal cancer.
@en
Predictive biomarkers with pot ...... metastatic colorectal cancer.
@nl
P2093
P2860
P921
P1476
Predictive biomarkers with pot ...... metastatic colorectal cancer.
@en
P2093
David Hersi Smith
Kirsten Vang Nielsen
Maria Unni Rømer
Niels Frank Jensen
Nils Brünner
Sune Boris Nygård
P2860
P304
P356
10.3109/00365521.2012.640835
P577
2011-12-19T00:00:00Z